Anish Konkar
AstraZeneca (Sweden)(SE)
Publications by Year
Research Areas
Diabetes Treatment and Management, Receptor Mechanisms and Signaling, Adipose Tissue and Metabolism, Neuropeptides and Animal Physiology, Regulation of Appetite and Obesity
Most-Cited Works
- → Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans(2013)661 cited
- → A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents(2014)614 cited
- → LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor(2017)351 cited
- → Cellular origins of cold‐induced brown adipocytes in adult mice(2014)282 cited
- → Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions(2013)241 cited
- → Robust anti‐obesity and metabolic effects of a dual GLP ‐1/glucagon receptor peptide agonist in rodents and non‐human primates(2016)234 cited
- → Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist(2021)163 cited
- → A novel glucagon‐like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice(2016)99 cited
- beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue.(2000)
- Aryloxypropanolamine and catecholamine ligand interactions with the beta(1)-adrenergic receptor: evidence for interaction with distinct conformations of beta(1)-adrenergic receptors.(2000)